These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25809736)

  • 21. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.
    Sachdeva MM; Eliott D
    Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A strategy to ensure safety of stem cell-derived retinal pigment epithelium cells.
    Choudhary P; Whiting PJ
    Stem Cell Res Ther; 2016 Sep; 7(1):127. PubMed ID: 27590276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.
    Du H; Lim SL; Grob S; Zhang K
    Semin Ophthalmol; 2011 May; 26(3):216-24. PubMed ID: 21609235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration.
    Parameswaran S; Balasubramanian S; Babai N; Qiu F; Eudy JD; Thoreson WB; Ahmad I
    Stem Cells; 2010 Apr; 28(4):695-703. PubMed ID: 20166150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-18 induces retinal pigment epithelium degeneration in mice.
    Ijima R; Kaneko H; Ye F; Nagasaka Y; Takayama K; Kataoka K; Kachi S; Iwase T; Terasaki H
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6673-8. PubMed ID: 25237159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concise Review: Update on Retinal Pigment Epithelium Transplantation for Age-Related Macular Degeneration.
    Zarbin M; Sugino I; Townes-Anderson E
    Stem Cells Transl Med; 2019 May; 8(5):466-477. PubMed ID: 30748126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cells in retinal regeneration: past, present and future.
    Ramsden CM; Powner MB; Carr AJ; Smart MJ; da Cruz L; Coffey PJ
    Development; 2013 Jun; 140(12):2576-85. PubMed ID: 23715550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells.
    Maruotti J; Wahlin K; Gorrell D; Bhutto I; Lutty G; Zack DJ
    Stem Cells Transl Med; 2013 May; 2(5):341-54. PubMed ID: 23585288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-184 regulates ezrin, LAMP-1 expression, affects phagocytosis in human retinal pigment epithelium and is downregulated in age-related macular degeneration.
    Murad N; Kokkinaki M; Gunawardena N; Gunawan MS; Hathout Y; Janczura KJ; Theos AC; Golestaneh N
    FEBS J; 2014 Dec; 281(23):5251-64. PubMed ID: 25251993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell-based treatment in geographic atrophy: promises and pitfalls.
    Kvanta A; Grudzinska MK
    Acta Ophthalmol; 2014 Feb; 92(1):21-6. PubMed ID: 23890249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration.
    Westenskow PD; Kurihara T; Friedlander M
    Adv Exp Med Biol; 2014; 801():323-9. PubMed ID: 24664714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs.
    Sharma R; Khristov V; Rising A; Jha BS; Dejene R; Hotaling N; Li Y; Stoddard J; Stankewicz C; Wan Q; Zhang C; Campos MM; Miyagishima KJ; McGaughey D; Villasmil R; Mattapallil M; Stanzel B; Qian H; Wong W; Chase L; Charles S; McGill T; Miller S; Maminishkis A; Amaral J; Bharti K
    Sci Transl Med; 2019 Jan; 11(475):. PubMed ID: 30651323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration.
    Kinnunen K; Petrovski G; Moe MC; Berta A; Kaarniranta K
    Acta Ophthalmol; 2012 Jun; 90(4):299-309. PubMed ID: 22112056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration.
    Mettu PS; Wielgus AR; Ong SS; Cousins SW
    Mol Aspects Med; 2012 Aug; 33(4):376-98. PubMed ID: 22575354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of T-cell activation by retinal pigment epithelial cells derived from induced pluripotent stem cells.
    Sugita S; Kamao H; Iwasaki Y; Okamoto S; Hashiguchi T; Iseki K; Hayashi N; Mandai M; Takahashi M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1051-62. PubMed ID: 25604685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonic stem cells as a treatment for macular degeneration.
    Pan CK; Heilweil G; Lanza R; Schwartz SD
    Expert Opin Biol Ther; 2013 Aug; 13(8):1125-33. PubMed ID: 23705996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deriving retinal pigment epithelium (RPE) from induced pluripotent stem (iPS) cells by different sizes of embryoid bodies.
    Muñiz A; Ramesh KR; Greene WA; Choi JH; Wang HC
    J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pluripotent human stem cells for the treatment of retinal disease.
    Rowland TJ; Buchholz DE; Clegg DO
    J Cell Physiol; 2012 Feb; 227(2):457-66. PubMed ID: 21520078
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.